drugset / Trial / NCT06842771
Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery
RandomizedParallel-groupTriple-blindSupportive care
Summary
We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.
Timeline
- Start
- 2025-03
- Primary completion
- 2026-02
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 20 ml | Other |
Indications
No indication recorded.